Pharmaceuticals Analysts, along with Steven Cohen, Associate Professor at the Department of Surgery at NYU Grossman School of Medicine discuss SpringWorks Ogsiveo on expected utilization in desmoid tumor on an Analyst/Industry conference call to be held on December 8 at 12 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SWTX:
- SpringWorks Therapeutics 9.483M share Spot Secondary priced at $29.00
- SpringWorks Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
- SpringWorks Therapeutics $250M Spot Secondary; price range $28.80-$30.00
- SpringWorks Therapeutics announces $250M common stock offering
- SpringWorks Therapeutics Announces Proposed Public Offering of Common Stock
